Role of Cerebroplacental Ratio Discordance at 16-20 Weeks in Predicting Monochorionic Twin Pregnancies' Specific Complications

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
AgeNot listed
SponsorAin Shams Maternity Hospital

About this trial

The purpose of this study is to evaluate the predictive value of CPR discordance at 16-20 weeks in MCDA twin pregnancies in predicting monochorionic-specific complications such as TTTS, TAPS, sFGR and IUFD of one or both fetuses

Eligibility criteria

Qualifiers

Aged 18 years or more and able to consent.

Monochorionic Diamniotic twin pregnancy.

Discordant inter-twin cerebroplacental ratio at 16-20 weeks of gestation.

Disqualifiers

Fetal structural malformations or chromosomal abnormalities in any of the twins as detected by anomaly scan antenatally or neonatal examination postnatally (chromosomal abnormalities and some congenital malformations can interfere with normal fetal growth).

Identified infectious etiologies detected during immediate postnatal examination or during pregnancy (fetal infections can cause FGR ,usually symmetric type particularly if they occur in early gestation).

Referral after development of Twin to twin transfusion syndrome, twin anemia polycythemia sequence or selective fetal growth restriction.

Single fetal demise at the time enrollment in the study.

Trial design

Treatments tested in this trial

  • Ultrasound

Treatment groups

No treatment groups listed

Sponsors and collaborators